Target-based Classification of Drugs

[ Brite menu | Download htext | Download json ]
    

1st Level  2nd Level  3rd Level  4th Level  5th Level 

     Type
 G Protein-coupled receptors
 
 Ion channels
 
 Nuclear receptors
 
 Protein kinases
 
 Cytokines and receptors
 
 Cell surface molecules and ligands
   Cell adhesion molecules: Ig superfamiy
   Cell adhesion molecules: other families
   Other cell surface molecules
     Immune checkpoints
       CTLA4 (CD152) [HSA:1493] [KO:K06538]
       PDCD1 (PD1, CD279) [HSA:5133] [KO:K06744]
         D10316  Nivolumab (USAN/INN) <JP/US>
         D10574  Pembrolizumab (USAN) <JP/US>
         D10390  Pidilizumab (USAN)
         D11108  Cemiplimab (USAN) <US>
         D11366  Dostarlimab (USAN)
         D11487  Tislelizumab (USAN/INN)
         D11488  Cetrelimab (USAN/INN)
         D11605  Spartalizumab (USAN/INN)
Monoclonal antibody
Monoclonal antibody
Monoclonal antibody
 
Monoclonal antibody
Monoclonal antibody
Monoclonal antibody
Monoclonal antibody
       PDL1 (CD274) [HSA:29126] [KO:K06745]
     CD molecules
     Other
 
 Transporters
 
 Enzymes
 
 Nucleic acids
 
 Not elsewhere classified

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: July 30, 2019

» Japanese version